Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Gavin Clark-Gartner's Stock Ratings
Evercore ISI Group Analyst
Gavin Clark-Gartner is an analyst at Evercore ISI Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
-5.23%
Smart Score
Overall Average Return Percentile
24th
Number of Ratings
40
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/15/2025 | DYN | Buy Now | Dyne Therapeutics | $19.44 | 85.19% | $38 → $36 | Maintains | Outperform | Get Alert | |
| 12/09/2025 | MIRM | Buy Now | Mirum Pharmaceuticals | $63.62 | 47.75% | $89 → $94 | Maintains | Outperform | Get Alert | |
| 12/08/2025 | VERA | Buy Now | Vera Therapeutics | $50.00 | 94% | $75 → $97 | Maintains | Outperform | Get Alert | |
| 12/01/2025 | EVMN | Buy Now | Evommune | $17.95 | 122.84% | → $40 | Initiates | → Outperform | Get Alert | |
| 11/25/2025 | FBRX | Buy Now | Forte Biosciences | $21.37 | 204.16% | → $65 | Initiates | → Outperform | Get Alert | |
| 10/31/2025 | ARGX | Buy Now | argenx | $828.46 | 9.84% | $775 → $910 | Maintains | Outperform | Get Alert | |
| 09/22/2025 | JSPR | Buy Now | Jasper Therapeutics | $1.77 | 691.59% | $20 → $14 | Maintains | Outperform | Get Alert | |
| 09/22/2025 | ABBV | Buy Now | AbbVie | $226.59 | -2.03% | $207 → $222 | Maintains | Outperform | Get Alert | |
| 08/08/2025 | MIRM | Buy Now | Mirum Pharmaceuticals | $63.62 | 39.89% | $77 → $89 | Maintains | Outperform | Get Alert | |
| 08/01/2025 | ABBV | Buy Now | AbbVie | $226.59 | -8.65% | $205 → $207 | Maintains | Outperform | Get Alert | |
| 07/08/2025 | JSPR | Buy Now | Jasper Therapeutics | $1.77 | 1030.84% | $50 → $20 | Maintains | Outperform | Get Alert | |
| 04/29/2025 | PRQR | Buy Now | ProQR Therapeutics | $2.35 | 112.77% | → $5 | Initiates | → Outperform | Get Alert | |
| 04/28/2025 | ABBV | Buy Now | AbbVie | $226.59 | -9.53% | $204 → $205 | Maintains | Outperform | Get Alert | |
| 01/28/2025 | MNMD | Buy Now | Mind Medicine | $12.70 | 81.1% | → $23 | Initiates | → Outperform | Get Alert | |
| 12/20/2024 | CABA | Buy Now | Cabaletta Bio | $2.40 | 150% | $15 → $6 | Downgrade | Outperform → In-Line | Get Alert | |
| 11/21/2024 | ARGX | Buy Now | argenx | $828.46 | -14.78% | $675 → $706 | Maintains | Outperform | Get Alert | |
| 11/07/2024 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 695.88% | $179 → $170 | Maintains | Outperform | Get Alert | |
| 08/26/2024 | JSPR | Buy Now | Jasper Therapeutics | $1.77 | 3575.22% | $65 → $65 | Maintains | Outperform | Get Alert | |
| 08/19/2024 | FHTX | Buy Now | Foghorn Therapeutics | $4.37 | 357.67% | → $20 | Initiates | → Outperform | Get Alert | |
| 08/12/2024 | KRYS | Buy Now | Krystal Biotech | $242.46 | -15.04% | $201 → $206 | Maintains | Outperform | Get Alert | |
| 08/12/2024 | CABA | Buy Now | Cabaletta Bio | $2.40 | 525% | $25 → $15 | Maintains | Outperform | Get Alert | |
| 08/08/2024 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 738.01% | $185 → $179 | Upgrade | In-Line → Outperform | Get Alert | |
| 08/08/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $63.62 | 3.74% | $62 → $66 | Maintains | Outperform | Get Alert | |
| 07/12/2024 | ARGX | Buy Now | argenx | $828.46 | -35.66% | $478 → $533 | Maintains | Outperform | Get Alert | |
| 06/24/2024 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 766.1% | $139 → $185 | Maintains | In-Line | Get Alert | |
| 04/03/2024 | JSPR | Buy Now | Jasper Therapeutics | $1.77 | 3575.22% | → $65 | Initiates | → Outperform | Get Alert | |
| 02/20/2024 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 546.07% | $108 → $138 | Maintains | In-Line | Get Alert | |
| 12/21/2023 | ARGX | Buy Now | argenx | $828.46 | -47.37% | $594 → $436 | Maintains | Outperform | Get Alert | |
| 10/17/2023 | MIRM | Buy Now | Mirum Pharmaceuticals | $63.62 | -2.55% | → $62 | Reinstates | → Outperform | Get Alert | |
| 10/03/2023 | ACRS | Buy Now | Aclaris Therapeutics | $3.23 | 582.17% | → $22 | Initiates | → Outperform | Get Alert | |
| 07/17/2023 | ARGX | Buy Now | argenx | $828.46 | -47.37% | → $436 | Reinstates | → Outperform | Get Alert | |
| 06/23/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 550.75% | → $139 | Downgrade | Outperform → Neutral | Get Alert | |
| 05/30/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 606.93% | $173 → $151 | Maintains | Outperform | Get Alert | |
| 05/30/2023 | CCCC | Buy Now | C4 Therapeutics | $2.45 | 307.91% | $20 → $10 | Maintains | Outperform | Get Alert | |
| 05/15/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 709.93% | $149 → $173 | Maintains | Outperform | Get Alert | |
| 04/13/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 597.57% | → $149 | Maintains | Outperform | Get Alert | |
| 03/01/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 700.56% | $135 → $171 | Maintains | Outperform | Get Alert | |
| 02/09/2023 | ABBV | Buy Now | AbbVie | $226.59 | -27.18% | $159 → $165 | Maintains | Outperform | Get Alert | |
| 12/20/2022 | ABBV | Buy Now | AbbVie | $226.59 | -32.04% | $156 → $154 | Maintains | Outperform | Get Alert | |
| 10/05/2022 | INBX | Buy Now | Inhibrx | $78.36 | -23.43% | $54 → $60 | Maintains | Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved